Sage Rhino Capital LLC Sanofi Transaction History

Sage Rhino Capital LLC

$419 Million
Q1 2025

A detailed history of Sage Rhino Capital LLC transactions in Sanofi stock. As of the latest transaction made, Sage Rhino Capital LLC holds 8,648 shares of SNY stock, worth $439,837. This represents 0.11% of its overall portfolio holdings.

Number of Shares

8,648

Previous 8,622 0.3%

Holding current value

$439,837

Previous $415,000 15.42%

% of portfolio

0.11%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	BUY	$48.15 - $59.42 $1,251 - $1,544	26 Added 0.3%	8,648 $479,000
Q4 2024 Feb 06, 2025	BUY	$45.89 - $57.31 $2,156 - $2,693	47 Added 0.55%	8,622 $415,000
Q3 2024 Nov 01, 2024	BUY	$48.54 - $58.53 $7,232 - $8,720	149 Added 1.77%	8,575 $494,000
Q2 2024 Jul 30, 2024	BUY	$45.39 - $50.36 $2,678 - $2,971	59 Added 0.71%	8,426 $408,000
Q1 2024 Apr 26, 2024	BUY	$45.75 - $52.48 $7,365 - $8,449	161 Added 1.96%	8,367 $406,000
Q4 2023 Feb 05, 2024	SELL	$43.13 - $54.79 $22,255 - $28,271	-516 Reduced 5.92%	8,206 $408,000
Q3 2023 Oct 26, 2023	BUY	$50.95 - $55.2 $12,228 - $13,248	240 Added 2.83%	8,722 $467,000
Q2 2023 Jul 31, 2023	SELL	$50.45 - $57.18 $4,389 - $4,974	-87 Reduced 1.02%	8,482 $457,000
Q1 2023 Apr 20, 2023	BUY	$45.86 - $54.45 $29,671 - $35,229	647 Added 8.17%	8,569 $466,000
Q4 2022 Jan 31, 2023	BUY	$38.86 - $48.55 $32,253 - $40,296	830 Added 11.7%	7,922 $383,000
Q3 2022 Oct 24, 2022	SELL	$37.22 - $100.5 $22,927 - $61,908	-616 Reduced 7.99%	7,092 $270,000
Q2 2022 Jul 28, 2022	BUY	$48.99 - $57.46 $10,140 - $11,894	207 Added 2.76%	7,708 $386,000
Q1 2022 Apr 27, 2022	BUY	$48.48 - $53.65 $145 - $160	3 Added 0.04%	7,501 $385,000
Q4 2021 Feb 04, 2022	SELL	$47.07 - $52.35 $2,730 - $3,036	-58 Reduced 0.77%	7,498 $376,000
Q3 2021 Oct 18, 2021	BUY	$47.89 - $53.12 $17,910 - $19,866	374 Added 5.21%	7,556 $364,000
Q2 2021 Jul 27, 2021	BUY	$49.36 - $54.25 $30,158 - $33,146	611 Added 9.3%	7,182 $378,000
Q1 2021 May 04, 2021	BUY	$45.46 - $50.51 $2,773 - $3,081	61 Added 0.94%	6,571 $325,000
Q4 2020 Feb 03, 2021	BUY	$45.3 - $51.62 $6,115 - $6,968	135 Added 2.12%	6,510 $316,000
Q2 2020 Jul 30, 2020	BUY	$42.91 - $52.5 $1,158 - $1,417	27 Added 0.43%	6,375 $325,000
Q1 2020 Apr 29, 2020	BUY	$38.02 - $51.66 $12,584 - $17,099	331 Added 5.5%	6,348 $278,000
Q4 2019 Jan 31, 2020	BUY	$44.25 - $50.86 $18,098 - $20,801	409 Added 7.29%	6,017 $311,000
Q3 2019 Oct 25, 2019	BUY	$40.34 - $46.64 $9,802 - $11,333	243 Added 4.53%	5,608 $260,000
Q2 2019 Aug 20, 2019	BUY	$40.43 - $44.3 $14,554 - $15,947	360 Added 7.19%	5,365 $232,000
Q1 2019 Apr 18, 2019	BUY	$40.83 - $45.43 $204,354 - $227,377	5,005 New	5,005 $222,000

Others Institutions Holding SNY

# of Institutions

856

Shares Held

269M

Call Options Held

1.48M

Put Options Held

1.34M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $128B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Account

Sage Rhino Capital LLC Sanofi Transaction History